Abstract: A method of braiding a stent includes braiding a number of elongate filaments around a mandrel using tensioned braiding carriers without spooling the filaments to the tensioned braiding carriers to form a braided stent having atraumatic ends.

Abstract: Obesity and related conditions and diseases pose ever increasing issues for the developed world. There is a need for interventions that can treat/prevent the underlying causes of e.g., diabetes and obesity. Accordingly compositions and methods for altering at least one expression level related to cellular metabolism are disclosed herein.

Abstract: In one embodiment, a method includes: retrieving data relevant to a first screen of an electronic program guide; generating a graphical user interface using the retrieved data, in which: a first node identifies the first screen; second nodes identify second screens accessed after the first screen, each of the second nodes being positioned to one side of the first node; the first node is connected to each of the second nodes by connectors, each of the connectors pointing towards each of the second nodes and having a width proportional to a volume of navigation flow received by each of the second nodes from the first node; wherein at least one node comprises a visual indication indicating an average time spent by the users on an identified screen of the electronic program guide; and rendering the generated graphical user interface on a display screen of the computing device.

Abstract: In one embodiment, a method includes: retrieving data relevant to a first screen of an electronic program guide; generating a graphical user interface using the retrieved data, in which: a first node identifies the first screen; second nodes identify second screens accessed after the first screen, each of the second nodes being positioned to one side of the first node; the first node is connected to each of the second nodes by connectors, each of the connectors pointing towards each of the second nodes and having a width proportional to a volume of navigation flow received by each of the second nodes from the first node; wherein at least one node comprises a visual indication indicating an average time spent by the users on an identified screen of the electronic program guide; and rendering the generated graphical user interface on a display screen of the computing device.

Abstract: A method of transmitting data traffic from a network node comprising the steps of identifying a plurality of data packets as being members of a data session adding a timestamp to the header or data payload of each packet within the session wherein the timestamp is an additional timestamp and transmitting the packets to their destination.

Abstract: A method for converting animal cells into brown adipose tissue cells is provided that includes transforming the animal cells using an expression vector. The expression vector includes a nucleotide sequence encoding HB-EGF operatively linked to a promoter and a nucleotide sequence encoding ADAM 12 operatively linked to a promoter. Converting animal cells to brown adipose tissue cells can be used to treat obesity or to treat cancer by converting target cells to brown adipose tissue cells.

Abstract: Substantially pure heparin-binding growth factor polypeptides (HBGFs), nucleic acids encoding the HBGFs and antibodies which bind to the HBGFs of the invention are provided. The HBGF polypeptides axe useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing.

Abstract: A method of transmitting data traffic from a network node comprising the steps of identifying a plurality of data packets as being members of a data session adding a timestamp to the header or data payload of each packet within the session wherein the timestamp is an additional timestamp and transmitting the packets to their destination.

Abstract: A method for converting animal cells into brown adipose tissue cells is provided that includes transforming the animal cells using an expression vector. The expression vector includes a nucleotide sequence encoding HB-EGF operatively linked to a promoter and a nucleotide sequence encoding ADAM 12 operatively linked to a promoter. Converting animal cells to brown adipose tissue cells can be used to treat obesity or to treat cancer by converting target cells to brown adipose tissue cells.

Abstract: Substantially pure heparin-binding growth factor polypeptides (HBGFs), nucleic acids encoding the HBGFs and antibodies which bind to the HBGFs of the invention are provided. The HBGF polypeptides are useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing.

Abstract: The present invention provides a method and apparatus for creating a packet using a digital signal processor. Call set-up information is received. Thereafter, call data is received and a data portion of the packet is created using the call data. One or more headers are created using the call data and the call set-up information. The packet is then created by attaching the one or more headers to the data portion of the packet. In addition, the one or more headers may include a real time transport protocol header, a user datagram protocol header, an Internet protocol header, and a media access control header.

Abstract: The present invention provides a method and apparatus for creating a packet using a digital signal processor. Call set-up information is received. Thereafter, call data is received and a data portion of the packet is created using the call data. One or more headers are created using the call data and the call set-up information. The packet is then created by attaching the one or more headers to the data portion of the packet. In addition, the one or more headers may include a real time transport protocol header, a user datagram protocol header, an Internet protocol header, and a media access control header.

Abstract: The present invention provides a method, apparatus and system for routing a message to a function instance within a packet operating system by receiving the message and requesting a destination address (label) for the function instance from a local repository. Whenever the destination address (label) is local, the message is sent to the function instance. Whenever the destination address (label) is remote, the message is packaged with the destination address (label) and the packaged message is sent to the function instance. Whenever the destination address (label) is not found, the destination address (label) for the function instance is requested from a remote repository, the message is then packaged with the destination address (label) and the packaged message is sent to the function instance. This method can be implemented using a computer program with various code segments to implement the steps of the method.

Abstract: The present invention provides a system and method for processing packetized data or packets through a communications switch using a Fast Flow-Forwarding (“FFF”) system. FFF provides expedited forwarding of packets based on pattern matching and data manipulation rules that cross protocol layer boundaries. More specifically, the present invention provides a method for processing a packet in which the packet is received and processed using one or more transformation rules whenever the packet satisfies one or more identification rules. Otherwise, the packet is processed using a standard process whenever the packet does not satisfy the one or more identification rules. This method can be implemented using a computer program having a code segment to execute each step of the method.

Abstract: Substantially pure heparin-binding growth factor polypeptides (HBGFs), nucleic acids encoding the HBGFs and antibodies which bind to the HBGFs of the invention are provided. The HBGF polypeptides are useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing.

Abstract: A method of reducing brain damage resulting from seizures caused by an organophosphorus nerve agent includes administering to a patient a therapeutically effective amount of HU-211. The organophosphorus nerve agent may be GB (sarin), GD (soman), GA (tabun) or GF. The therapeutically effective amount of HU-211 is in the range of about 48 mg to about 200 mg per day.

Abstract: Substantially pure heparin-binding growth factor polypeptides (HBGFs), nucleic acids encoding the HBGFs and antibodies which bind to the HBGFs of the invention are provided. The HBGF polypeptides are useful in methods for the induction of bone, cartilage and tissue formation, growth and development of the endometrium and in the acceleration of wound healing. HBGF is related to Connective Tissue Growth Factor (CTGF).